These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 7553649)

  • 61. Differential protease expression by cutaneous squamous and basal cell carcinomas.
    Sappino AP; Belin D; Huarte J; Hirschel-Scholz S; Saurat JH; Vassalli JD
    J Clin Invest; 1991 Oct; 88(4):1073-9. PubMed ID: 1918364
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential regulation of plasminogen activators by epidermal growth factor in normal and neoplastic human urothelium.
    Dubeau L; Jones PA; Rideout WM; Laug WE
    Cancer Res; 1988 Oct; 48(19):5552-6. PubMed ID: 3138024
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis.
    Ronday HK; Smits HH; Van Muijen GN; Pruszczynski MS; Dolhain RJ; Van Langelaan EJ; Breedveld FC; Verheijen JH
    Br J Rheumatol; 1996 May; 35(5):416-23. PubMed ID: 8646430
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunohistochemical demonstration of the plasminogen activator system in human gingival tissues and gingival fibroblasts.
    Xiao Y; Bunn CL; Bartold PM
    J Periodontal Res; 1998 Jan; 33(1):17-26. PubMed ID: 9524317
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Human primary colon carcinomas xenografted into nude mice. II. Modulation of tumor plasminogen activator activity by the host tissue environment.
    Cajot JF; Sordat B; Bachmann F
    J Natl Cancer Inst; 1986 Nov; 77(5):1099-107. PubMed ID: 3095580
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Induction of tissue-type plasminogen activator by ionizing radiation in human malignant melanoma cells.
    Boothman DA; Wang M; Lee SW
    Cancer Res; 1991 Oct; 51(20):5587-95. PubMed ID: 1913677
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Use of mouse models to study plasminogen activator inhibitor-1.
    Declerck PJ; Gils A; De Taeye B
    Methods Enzymol; 2011; 499():77-104. PubMed ID: 21683250
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Plasminogen activator in acute myeloid leukaemic marrows: u-PA in contrast to t-PA in normal marrow.
    McWilliam N; Robbie L; Booth N; Bennett B
    Br J Haematol; 1998 Jun; 101(4):626-31. PubMed ID: 9674732
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fibrinolytic activity and localization of plasminogen activator in bovine vitreous body and aqueous humor.
    Hayashi K; Nakashima Y; Sueishi K; Tanaka K
    Jpn J Ophthalmol; 1989; 33(1):66-75. PubMed ID: 2499726
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Plasminogen activator activity in bone metastases of prostatic carcinomas as compared to primary tumors.
    Kirchheimer JC; Pflüger H; Ritschl P; Hienert G; Binder BR
    Invasion Metastasis; 1985; 5(6):344-55. PubMed ID: 4066206
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Plasminogen activators in human malignant melanoma.
    Markus G; Kohga S; Camiolo SM; Madeja JM; Ambrus JL; Karakousis C
    J Natl Cancer Inst; 1984 Jun; 72(6):1213-22. PubMed ID: 6374238
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fibrinolysis activity promotes tumor invasiveness of B16 melanoma cell lines through a reconstituted gel matrix.
    Mimura K; Sueishi K; Yasunaga C; Tanaka K
    Invasion Metastasis; 1992; 12(1):24-34. PubMed ID: 1380952
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Correlation between urokinase-type plasminogen activator production and the metastatic ability of human rectal cancer cells.
    Marutsuka K; Suzumiya J; Kataoka H; Komada N; Koono M; Sumiyoshi A
    Invasion Metastasis; 1991; 11(4):181-91. PubMed ID: 1765431
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Plasminogen activator system in osteoclasts.
    Yang JN; Allan EH; Anderson GI; Martin TJ; Minkin C
    J Bone Miner Res; 1997 May; 12(5):761-8. PubMed ID: 9144342
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Urokinase-type and tissue-type plasminogen activators have different distributions in cultured bovine capillary endothelial cells.
    Moscatelli D
    J Cell Biochem; 1986; 30(1):19-29. PubMed ID: 3082899
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Malignant mouse melanoma cells do not form tumors when mixed with cells of a non-malignant subclone: relationships between plasminogen activator expression by the tumor cells and the host's immune response.
    Newcomb EW; Silverstein SC; Silagi S
    J Cell Physiol; 1978 May; 95(2):169-77. PubMed ID: 306389
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice.
    Ahn MY; Zhang ZG; Tsang W; Chopp M
    Brain Res; 1999 Aug; 837(1-2):169-76. PubMed ID: 10433999
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Production of urokinase-type plasminogen activator (u-PA) and plasminogen activator inhibitor-1 (PAI-1) in human brain tumours.
    Arai Y; Kubota T; Nakagawa T; Kabuto M; Sato K; Kobayashi H
    Acta Neurochir (Wien); 1998; 140(4):377-85; discussion 385-6. PubMed ID: 9689330
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.
    Hu ZY; Liu YX; Liu K; Byrne S; Ny T; Feng Q; Ockleford CD
    J Anat; 1999 Feb; 194 ( Pt 2)(Pt 2):183-95. PubMed ID: 10337950
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Tissue plasminogen activator and urokinase in normal, dysplastic and cancerous squamous epithelium of the uterine cervix.
    Larsson G; Larsson A; Astedt B
    Thromb Haemost; 1987 Oct; 58(3):822-6. PubMed ID: 3124284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.